Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2008
12/18/2008US20080312302 Desferasirox Dispersible Tablets
12/18/2008US20080312301 Substituted N-Benzo[D]Isoxazol-3-Yl-Amine Compounds as Inhibitors of Mglur5, Serotonin (5-Ht) and Noradrenaline Receptors, and Uses Thereof
12/18/2008US20080312300 Processes for the Preparation of Stable Polymorphic Form I of Ritonavir
12/18/2008US20080312299 Imidazole Derivatives as Fructose-1,6-Bisphosphatase Inhibitors and Pharmaceutical Compositions Containing Them
12/18/2008US20080312298 Methods for Identification of Modulators of Carm1 Methyl Transferase Activity
12/18/2008US20080312296 Bifunctional synthetic molecules
12/18/2008US20080312295 Pesticidal Mixtures
12/18/2008US20080312294 (4 beta S,7R,8 alpha R)-4 beta -benzyl-7-hydroxy-N-(2-methylpyridin-3-yl)-7-(trifluoromethyl)-4 beta ,5,6,7,8,8 alpha ,9,10-octahydrophenanthrene-2-carboxamide; glucocorticoid receptor modulators; antiinflammatory agents; Alzheimer's disease; side effect reduction
12/18/2008US20080312293 2-Arylpropionic Acid Derivatives and Pharmaceutical Compositions Containing Them
12/18/2008US20080312292 Antipruritics
12/18/2008US20080312291 Heterocyclic Gaba-b Modulators
12/18/2008US20080312288 Solid forms of 2-chloro-4-[1-(4-fluoro-phenyl)-2,5-dimethyl-1h-imidazol-4-ylethynyl]-pyridine
12/18/2008US20080312287 Compound and Methods For the Treatment of Cancer and Malaria
12/18/2008US20080312286 Indanone Potentiators of Metabotropic Glutamate Receptors
12/18/2008US20080312285 Substituted Indazoles as Inhibitors of Phosphodiesterase Type-Iv
12/18/2008US20080312284 3-(2-cyanophenyl)-5-(2-pyridyl)-1-phenyl-1,2-dihydropyridine-2-one; antagonistic action against AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) receptor and/or inhibitory action against kainate receptor prophylactic agent for neurodegenerative diseases
12/18/2008US20080312283 Use of Hydroxylamine Derivates for Inhibiting Vitrectomy-Induced Cataracts
12/18/2008US20080312282 Inhibitors of Diacylglycerol O-acyltransferase Type 1 Enzyme
12/18/2008US20080312281 G-Protein Coupled Receptor (Gpr116) Agonists and Use Thereof for Treating Obesity and Diabetes
12/18/2008US20080312280 3- (4-{ [4- (4-{ [3-(3, 3-Dimethyl-1-Piperidinyl) Propyl] Oxy} Phenyl) -1-Piperidinyl] Carbonyl}-1-Naphthalenyl) Propanoic or Propenoic Acid as H1 and H3 Receptor Antagonists for the Treatment of Inflammatory and/or Allergic Disorders
12/18/2008US20080312279 Compositions for Treating Fragile X and Other Disorders Methods of Use Thereof, and Screening for Compounds for Fragile X and Other Disorders
12/18/2008US20080312278 Hydroxyquinoline Derivatives
12/18/2008US20080312277 Gpr41 and Modulators Thereof for the Treatment of Insulin-Related Disorders
12/18/2008US20080312276 4,5 Dihydro-(1H)-Pyrazole Derivatives as Cannabinoid CB1 Receptor Modulators
12/18/2008US20080312275 Novel Cyanoguanidine Compounds
12/18/2008US20080312274 Quinoline Derivatives as Neurokinin Receptor Antagonists
12/18/2008US20080312273 Quinoline Derivatives Having Vegf Inhibiting Activity
12/18/2008US20080312272 Aryloazol-2-yl cyanoethylamino compounds, method of making and method of using thereof
12/18/2008US20080312271 Azabenzimidazolyl compounds
12/18/2008US20080312270 Compounds and methods useful for treating asthma and allergic inflammation
12/18/2008US20080312269 Therapeutic Agents
12/18/2008US20080312268 Substituted tricyclic piperidone compounds
12/18/2008US20080312267 Diagnosis and Treatment of Diseases Arising from Defects in the Tuberous Sclerosis Pathway
12/18/2008US20080312266 Steroidal Compounds For Inhibiting Steroid Sulphatase
12/18/2008US20080312265 Treatment of Drug-Resistant Tumors
12/18/2008US20080312264 Process for the production of an abuse-proofed solid dosage form
12/18/2008US20080312263 Pharmaceutical compositions for the prevention and treatment of atherosclerosis
12/18/2008US20080312262 Such as 2-(methylamino)-2-oxoethyl {2-[(4-chlorophenyl)oxy]ethyl}carbamate; sleep disorders
12/18/2008US20080312261 4- (4-Bromo-2-Fluoroanilino) -6- Methoxy-7- (1-Methylpiperidin-4-Ylmethoxy) Quinazoline Monohydrate
12/18/2008US20080312260 Biological markers predictive of anti-cancer response to kinase inhibitors
12/18/2008US20080312259 SALTS OF THE JANUS KINASE INHIBITOR (R)-3-(4-(7H-PYRROLO[2,3-d]PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL)-3-CYCLOPENTYLPROPANENITRILE
12/18/2008US20080312258 METABOLITES OF THE JANUS KINASE INHIBITOR (R)-3-(4-(7H-PYRROLO[2,3-d]PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL)-3-CYCLOPENTYLPROPANENITRILE
12/18/2008US20080312257 Triazolopyrimidine derivatives as ADP P2Y12 receptor antagonists
12/18/2008US20080312256 Organic Compounds
12/18/2008US20080312255 Piperdine compounds and uses thereof-911
12/18/2008US20080312254 Process for the Preparation of Ziprasidone
12/18/2008US20080312253 Pharmaceutical compositions containing pyrazole derivatives for treating as serotonin antagonist
12/18/2008US20080312252 Combination of Organic Compounds
12/18/2008US20080312251 Aminopyrimidine Compounds and Their Salts, Process for Preparation and Pharmaceutical Use Thereof
12/18/2008US20080312250 Combination Comprising a Bcrp Inhibitor and 4- (4-Methylpiperazin-1-Ylmethyl)-N-[4-Methyl-3- (4-Pyridin-3-Yl) Pyrimidin-2-Ylamino) Phenyl] -Benzamide
12/18/2008US20080312249 Kmup-1 capable of treating hypertension
12/18/2008US20080312248 Pyrimidinyl Aryl Urea Derivatives Being Fgf Inhibitors
12/18/2008US20080312247 Substituted piperazines
12/18/2008US20080312246 Substituted Piperazines as Metabotropic Glutamate Receptor Antagonists
12/18/2008US20080312245 Methods and compositions for treating acne and other infectious diseases
12/18/2008US20080312244 Squaric Acid Derivatives as Protein Kinase Inhibitors
12/18/2008US20080312243 Imidazoles and triazoles, their preparation, and their use as pharmaceutical compositions
12/18/2008US20080312242 7-aryl-3, 9-diazabicyclo(3.3.1)non-6-ene derivatives and their use as renin inhibitors in the treatment of hypertension, cardiovascular or renal diseases
12/18/2008US20080312241 Cicletanine and PKC inhibitors in the treatment of pulmonary and cardiac disorders
12/18/2008US20080312240 Bicyclic Piperazines as Metabotropic Glutatmate Receptor Antagonists
12/18/2008US20080312239 Methods for the treatment of erectile dysfunction using fispemifene
12/18/2008US20080312238 4-Arylazo-3,5-Diamino-Pyrazole Compounds and Use Thereof
12/18/2008US20080312237 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
12/18/2008US20080312236 3-Heteroaryl-3-Hydroxy-2-Amino-Propyl Amines And Related Compounds Having Analgesic And/Or Immuno Stimlant Activity
12/18/2008US20080312235 Pyridine Derivatives
12/18/2008US20080312234 Novel compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same
12/18/2008US20080312233 Therapeutic Morpholino-Substituted Compounds
12/18/2008US20080312232 N-(3-fluoro-4-(6-(pyrrolidine-1-carboxamido)pyridin-4-yloxy)phenyl)-1-(2-hydroxy-2-methylpropyl)-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazole-4-carboxamide, used for prophylaxis and treatment of hepatocyte growth factor mediated diseases, such as cancer and angiogenesis
12/18/2008US20080312231 N-{2-[2-(4-benzyl-4-hydroxy-piperidin-1-yl)-2-oxo-ethoxy]-ethyl}-N-ethyl-4-methoxy-2,3,6-trimethyl-phenylsulfonamide; condensing the N-carboxyalkyl phenylsulfonamide with the substituted piperidine; bradykinin receptor antagonists; analgesics; antidiabetics; angiogenesis inhibitors; rheumatic diseases
12/18/2008US20080312230 Organic Compounds
12/18/2008US20080312229 Organic Compounds
12/18/2008US20080312228 Pyrimidine compound and medical use thereof
12/18/2008US20080312227 Substituted Pyrido(2,3-D) Pyrimidine Derivatives Useful as Medicines for the Treatment of Autoimmune Disorders
12/18/2008US20080312226 Amide Compound
12/18/2008US20080312225 Triazolophthalazines
12/18/2008US20080312224 Oxaphenanthrene Derivatives
12/18/2008US20080312223 Thiazole And Isothiazole Derivatives That Modulate The Activity Of CDK, GSK And Aurora Kinases
12/18/2008US20080312222 4-Benzyledene-Piperidin Derivatives
12/18/2008US20080312221 Quinoline derivative and quinazoline derivative inhibiting self-phosphorylation of hepatocytus proliferator receptor, and medicinal composition containing the same
12/18/2008US20080312220 Oxadiazole Derivatives with Crth2 Receptor Activity
12/18/2008US20080312219 Biologically active methylene blue derivatives
12/18/2008US20080312218 Fused tetracyclic mglur1 antagonists as therapeutic agents
12/18/2008US20080312217 N,N'-Bis-{4-[N'-(3,5-diamino-6-chloro-pyrazine-2-carbonyl)-guanidino]-butyl}terephthalamide, used for the treatment of conditions mediated by the blockade of an epithelial sodium channels
12/18/2008US20080312216 Piperazine and [1,4]diazepan derivatives as nk antagonists
12/18/2008US20080312215 Substituted [1,4]-diazepanes as CXCR3 antagonists and their use in the treatment of inflammatory disorders
12/18/2008US20080312214 Treating non-insulin dependent diabetes, insulin resistance, obesity, lipid disorders, metabolic syndrome; 6-[(1-cycloheptyl-4,4-dimethyl-5-oxopyrrolidin-3-yl)methoxy]nicotinonitrile for example
12/18/2008US20080312213 7-Pyrazolylbenzazepines Having Affinity For D3 Receptor
12/18/2008US20080312212 Organic Compounds
12/18/2008US20080312211 Antibacterial Pyrrolopyridines, Pyrrolopyrimidines and Pyrroloazepines-154
12/18/2008US20080312210 Use of a specific cyclic amine derivative or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure
12/18/2008US20080312209 Piperazine Heteroaryl Derivatives as Gpr38 Agonists
12/18/2008US20080312208 Pyridine Analogues
12/18/2008US20080312207 Compounds
12/18/2008US20080312206 Chemical Compounds-149
12/18/2008US20080312205 Method and intermediates for the preparation of derivatives of n (1-benzhydrylazetidin-3-yl)-n-phenylmethylsulfonamide
12/18/2008US20080312204 Soluble forms of amoxicillin and treatment of animals
12/18/2008US20080312203 such as (5R,6Z)-6-[(5-benzyl-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl)methylene]-7oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid, in combination with beta-lactam antibiotics, for the treatment of bacterial infections
12/18/2008US20080312202 6-substituted estradiol derivatives and methods of use
12/18/2008US20080312201 Reduced Toxicity Methotrexate Formulations and Methods for Using the Same
12/18/2008US20080312200 Medicament Comprising A Hormone Combination
1 ... 2946 2947 2948 2949 2950 2951 2952 2953 2954 2955 2956 2957 2958 2959 2960 2961 2962 2963 2964 2965 2966 ... 7860